Food Enzymes
Enzymes used as processing aids or functional ingredients in food manufacturing, subject to safety assessment, production strain characterisation, and purity requirements.
Foresight tracks Food Enzymes developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
Cooling
50% below the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
9 May 2026, 07:16
Latest Food Enzymes alerts
The most recent regulatory and guidance signals tracked by Foresight
EU Implementing Regulation Renews Authorisation for Talaromyces versatilis Enzyme Feed Additive for Poultry (Adisseo France)
The European Commission has adopted a new implementing regulation that renews and consolidates EU authorisation for Adisseo’s Talaromyces versatilis enzyme preparation (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed additive across a broad range of poultry categories. This secures continued EU market access for these enzyme formulations while repealing earlier implementing regulations, so feed and premix manufacturers should check the consolidated authorisation for any updated conditions of use or labelling once the final text is available.
European UnionEU EFSA Consults on Authorisation of Trypsin and Chymotrypsin (Porcine Pancreas) as New Food Enzyme
EFSA is running an EU-level public consultation, closing 17 November 2026, on an application to authorise trypsin and chymotrypsin from porcine pancreas as a new food enzyme under the EU Food Enzymes Regulation. Food and beverage manufacturers using enzymatic processing should track this dossier as a potential new tool that could widen formulation options while creating specific conditions and documentation expectations for compliant use across the EU single market.
European UnionEFSA Ongoing Risk Assessment of Glucan 1,4-Alpha-Glucosidase Food Enzyme from GM Trichoderma reesei DP-Nzh120 (EFSA-Q-2025-00434)
EFSA is assessing an application under EU food enzyme legislation to authorise glucan 1,4-alpha-glucosidase (glucoamylase, CAS 9032-08-0) from genetically modified Trichoderma reesei strain DP-Nzh120 as a new food enzyme, with the question EFSA-Q-2025-00434 currently in ongoing risk assessment and a portal deadline of 13 July 2026. Food and beverage manufacturers relying on starch-processing enzymes should track this consultation-stage dossier and potential EFSA opinion, as any eventual authorisation decision could shape which enzymes are permitted and under what conditions in EU food production.
European UnionCanada Authorises Transglutaminase From Bacillus Licheniformis NZYM-TR In List Of Permitted Food Enzymes
On 14 April 2026, Health Canada amended the List of Permitted Food Enzymes to authorise transglutaminase from Bacillus licheniformis NZYM-TR for use across a wide range of plant- and animal-based foods at Good Manufacturing Practice levels. This opens new formulation options for meat, dairy and plant-based products in Canada, but manufacturers using this enzyme must align specifications, labelling and documentation with the updated additive approval.
CanadaEFSA Ongoing Risk Assessment of Food Enzyme Xylanase from Aspergillus Luchuensis AR-682 (AB Enzymes)
EFSA has been assessing since March 2023 the safety of AB Enzymes’ food enzyme xylanase, produced with Aspergillus luchuensis strain AR-682, under the EU Food Enzymes Regulation, with the OpenEFSA register showing the question as still in ongoing risk assessment. With an estimated risk-assessment deadline at the end of 2027 and no opinion yet published, this file signals a potential future authorisation decision that EU-focused food and ingredient manufacturers should track for implications on enzyme sourcing, formulations, and labelling.
European UnionEFSA Concludes No Safety Concern for Food Enzyme (Leucyl Aminopeptidase, Oryzin, Aspergillopepsin I) From Aspergillus sp. Strain AE-PR
In April 2026 EFSA issued a scientific opinion concluding that a multi-enzyme food preparation from non-genetically modified Aspergillus sp. strain AE-PR does not raise safety concerns at the intended use levels. This provides a strong scientific basis for forthcoming EU authorisation decisions across multiple food processes, with a very high margin of exposure and only limited residual allergenicity risks, allowing enzyme suppliers and food manufacturers to plan formulations and approvals with greater confidence.
European UnionEFSA Safety Evaluation of Food Enzyme Arabinan Endo‑1,5‑α‑L‑Arabinanase From Aspergillus tubingensis ARS R7‑60
In April 2026 the EFSA Panel on Food Enzymes concluded that the food enzyme arabinan endo-1,5-α-L-arabinanase from non-GM Aspergillus tubingensis ARS R7-60 does not raise safety concerns at proposed use levels in specified fruit, vegetable and alcoholic beverage processes. This positive risk assessment supports potential EU authorisation of the enzyme for certain applications, but manufacturers must note that EU fruit juice rules still prohibit arabinanases in juice processing, so any future approvals are likely to exclude that use and should be monitored closely.
European UnionMalta Adopts Preserved Milk (Amendment) Regulations 2026 Implementing Directive (EU) 2024/1438
Malta has adopted the Preserved Milk (Amendment) Regulations 2026 to transpose EU Directive 2024/1438, updating composition, labelling, and additive rules for preserved milk products with effect from 14 June 2026. Dairy and food manufacturers supplying the Maltese market should review recipes and labelling against the new lactose-reduction, evaporated milk standard, and authorised additive and enzyme provisions, using the limited transition for pre-2026 stock to manage changeover.
MaltaEFSA Concludes AMP Deaminase Food Enzyme From GM Bacillus subtilis (CCTCC M 2023264) Is Safe for Yeast Processing
In March 2026, EFSA’s Panel on Food Enzymes concluded that an AMP deaminase food enzyme produced by genetically modified Bacillus subtilis strain CCTCC M 2023264 is safe for use in processing yeast and yeast products at the proposed use levels. This positive opinion under the EU food enzymes framework strongly signals likely future authorisation of this GMO-derived processing aid, allowing yeast and ingredient manufacturers to plan applications while monitoring subsequent Union list decisions.
European UnionEFSA Updates Safety Evaluation of Subtilisin from Genetically Modified Bacillus licheniformis NZYM-CB for Nine Food Manufacturing Processes
EFSA’s Food Enzymes Panel has adopted a 12 March 2026 opinion confirming that the food enzyme subtilisin from genetically modified Bacillus licheniformis NZYM‑CB remains safe when its authorised uses are expanded from six to nine food manufacturing processes across dairy, protein hydrolysates, brewing and plant‑based products. This positive scientific assessment signals that EU approval for broader enzyme use is likely to proceed, enabling reformulation and process efficiency for food and enzyme manufacturers while maintaining conservative exposure margins for European consumers.
European UnionEFSA Evaluates Safety of Glucan 1,4‑α‑Glucosidase From GM Trichoderma reesei DP‑Nzh109
EFSA has confirmed the safety of glucan 1,4-α-glucosidase from genetically modified Trichoderma reesei for starch and distilled alcohol production. This positive assessment clears a major regulatory hurdle for formal EU authorization, securing the compliance pathway for food and beverage manufacturers.
European UnionEU EFSA Panel Evaluates Extension Of Use For Food Enzyme Glucan 1,4‑α‑Maltohydrolase (NZYM‑SD)
EFSA has issued a positive safety opinion for extending the use of the food enzyme glucan 1,4-alpha-maltohydrolase to five food manufacturing processes including plant-based milk analogues. This assessment clears a major technical hurdle for expanded market access and provides regulatory certainty for manufacturers using this enzyme in diverse food categories.
European UnionEFSA Consults on Extension of Use of Alpha-Amylase Food Enzyme (GM Bacillus licheniformis NZYM-AV)
EFSA is consulting on the expanded use of alpha-amylase derived from genetically modified Bacillus licheniformis through April 2026. Successful authorization would broaden market access for this enzyme in food processing while requiring updates to formulation compliance and labeling.
European UnionEFSA Consults on Extension of Use for Food Enzyme Endo-1,4-β-Xylanase (Bacillus licheniformis NZYM-CE)
EFSA has launched a consultation on extending the permitted uses for the food enzyme endo-1,4-beta-xylanase produced through genetic modification. Stakeholders should assess the proposed application to anticipate changes in authorization conditions that will impact food improvement agent compliance and EU market access.
European UnionEFSA Adopts Opinion on Extension of Use of Cellulase Food Enzyme From GM Trichoderma reesei AR-852
EFSA issued a positive safety opinion in March 2026 supporting the expanded use and revised levels for cellulase enzymes derived from genetically modified sources. This scientific clearance facilitates the formal authorization of broader applications across the food and beverage sectors, including brewing and juice production.
European UnionEU EFSA Updates Safety Evaluation Of Cellulase Food Enzyme From GM Trichoderma reesei AR-852
EFSA has issued a positive safety opinion for the expanded use and revised concentration levels of cellulase from GM Trichoderma reesei in food manufacturing. This scientific endorsement facilitates the formal EU authorization process, enabling broader application and updated use levels for food processing operations.
European UnionEU EFSA Registers Intake of Application to Modify Phospholipase C Food Enzyme (Bacillus licheniformis NZYM-VR)
EFSA has formally registered an application to modify the authorization for the food enzyme phospholipase C produced by Bacillus licheniformis. This initiates a technical safety review that could lead to updated usage specifications or market access conditions for food and beverage manufacturers.
European UnionEFSA Intake of Application for Alpha-Amylase Food Enzyme From GM Komagataella Phaffii
EFSA has initiated the formal safety assessment for a new alpha-amylase food enzyme produced from genetically modified microorganisms. Authorization would expand the portfolio of approved processing aids while establishing the specific purity and safety standards required for EU market access.
European UnionSouth Korea MFDS Consults On Draft Safety Review For GM Microorganism-Derived Cellulase Food Additive
South Korea is reviewing the safety of a cellulase food additive derived from genetically modified microorganisms with a consultation closing in April 2026. Successful assessment would provide a regulatory pathway for biotech-derived enzymes in the food sector, necessitating rigorous scientific data alignment for market entry.
South KoreaEU EFSA Extends Clock Stop In Risk Assessment Of Cellulase And Hemicellulase Food Enzyme From Aspergillus luchuensis AE-C
EFSA has extended the risk assessment timeline for cellulase and hemicellulase food enzymes, with a new indicative completion date of April 2028. This delay prolongs regulatory uncertainty and requires manufacturers to adjust market entry strategies and product development timelines for these specific enzyme preparations.
European UnionRelated topics
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Food Enzymes alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
